Full field optical coherence tomography of prostate biopsies: A step towards pre-histological diagnosis?

Progres en Urologie

Volumn 24, Issue 1, 2014, Pages 22-30

  Beuvon, F ^a   Dalimier, E ^b   Cornud, F ^a   Barry Delongchamps, N ^a  

^a Institut Cochin   (France)

^b LLTECH SAS   (France)

Author keywords

Biopsy; Full field OCT; Histology; Prostate cancer

Indexed keywords

ARTICLE; BIOPSIES; BIOPSY; CANCER DE LA PROSTATE; FEASIBILITY STUDY; FULL FIELD OCT; HISTOLOGIE; HISTOLOGY; HUMAN; MALE; OCT PLEIN CHAMP; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PILOT STUDY; PROSTATE; PROSTATE CANCER; PROSTATE TUMOR;

BIOPSIES; BIOPSY; CANCER DE LA PROSTATE; FULL FIELD OCT; HISTOLOGIE; HISTOLOGY; OCT PLEIN CHAMP; PROSTATE CANCER;

BIOPSY; FEASIBILITY STUDIES; HUMANS; MALE; PILOT PROJECTS; PROSTATE; PROSTATIC NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84890876371     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2013.05.008     Document Type: Article

References (22)

1. Dubois A., Vabre L., Boccara A.C., Beaurepaire E. High-resolution full-field optical coherence tomography with a Linnik microscope. Appl Opt 2002, 41:805-812.
2. Ouzzane A., Coloby P., Mignard J.P., Allegre J.P., Soulie M., Rebillard X., et al. Committee of Infectious Diseases of the French Association of Urology (CIAFU); Committee of Cancerology of the French Association of Urology (CCAFU). Recommendations for best practice for prostate biopsy. Prog Urol 2011, 21:18-28.
3. Fercher A.F. Optical coherence tomography. J Biomed Opt 1996, 1:157-173.
4. Fujimoto F.J., Brezinski M.E., Tearney G.J., Bopart S.A., Bouma B.E., Hee M.R., et al. Optical biopsy and imaging using optical coherence tomography. Nature Med 1995, 1:970-972.
5. Trefford S., Desmond F. Optical coherence tomography of the anterior segment. Ocul Surf 2008, 6:117-127.
6. Lerner S.P., Goh A.C., Tresser N.J., Shen S.S. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 2008, 72:133-137.
7. Rais-Bahrami S., Levinson A.W., Fried N.M., Lagoda G.A., Hristov A., Chuang Y., et al. Optical coherence tomography of cavernous nerves: a step toward real-time intraoperative imaging during nerve-sparing radical prostatectomy. Urology 2008, 72:198-204.
8. Linehan J.A., Bracamonte E.R., Hariri L.P., Sokoloff M.H., Rice P.S., Barton J.K., et al. Feasibility of optical coherence tomography imaging to characterize renal neoplasms: limitations in resolution and depth of penetration. BJU Int 2011, 108:1820-1824.
9. Jain M., Shukla N., Manzoor M., Nadolny S., Mukherjee S. Modified full-field optical coherence tomography: a new tool for rapid histology of tissues. J Pathol Inform 2011, 2:28.
10. Dalimier E., Salomon D. Full-field optical coherence tomography: a new technology for 3D high-resolution skin imaging. Dermatology 2012, 224:84-92.
11. Assayag O., Antoine M., Sigal-Zafrani B., Riben, Harms F., Burcheri A., et al. Large field high resolution full-field optical coherence tomography: a pre-clinical study of human breast tissue and cancer assessment. Technol Cancer Res Treat Express 2013, 1(1):21-34.
12. Assayag O, Grieve K, Devaux B, Harms F, Pallud J, Chretien F, Boccara C, Varlet P. Imaging of non tumorous and tumorous human brain tissue with full-field optical coherence tomography. Submitted in NeuroImage: Clinical. In press.
13. Ramasamy R., Sterling J., Manzoor M., Salamoon B., Jain M., Fisher E.S., et al. Full field optical coherence tomography can identify spermatogenesis in a rodent sertoli cell only model. J Pathol Inform 2012, 3:4-8.
14. Villers A., Puech P., Mouton D., Leroy X., Ballereau C., Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006, 176:2432-2437.
15. Delongchamps N.B., Beuvon F., Eiss D., Flam T., Muradyan N., Zerbib M., et al. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer. Prostate Cancer Prostatic Dis 2011, 14:232-237.
16. Turkbey B., Mani H., Shah V., Rastinehad A.R., Bernardo M., Pohida T., et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011, 186:1818-1824.
17. Park B.K., Park J.W., Park S.Y., Kim C.K., Lee H.M., Jeon S.S., et al. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol 2011, 197:W876-W881.
18. Haffner J., Lemaitre L., Puech P., Haber G.P., Leroy X., Jones J.S., et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 2011, 108:171-178.
19. Belas O., Klap J., Cornud F., Beuvon F., Peyromaure M., Zerbib M., et al. [Prebiopsymultiparametric MRI of the prostate: the end of randomized biopsies?]. Prog Urol 2012, 22:583-589.
20. Delongchamps N.B., Peyromaure M., Schull A., Beuvon F., Bouazza N., Flam T., et al. Pre-biopsy Magnetic Resonance Imaging and prostate cancer detection: comparison of random and MRItargeted biopsies using three different techniques of MRI-TRUS image registration. J Urol 2012, 189:493-499.
21. Portalez D., Mozer P., Cornud F., Renard-Penna R., Misrai V., Thoulouzan M., et al. Validation of the European society of urogenital radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 2012, 62:986-996.
22. Pacelli A., Lopez-Beltran A., Egan A.J., Botswick D.G. Prostatic adenocarcinoma with glomeruloid features. Hum Pathol 1998, 29:543-546.